Welcome to the 2 Minute Medicine® Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence.
We begin this episode by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.”
(00:00) Introduction.
(01:22) First article of the week.
In the second half of our episode, we bring a medical eye to popular events. In this episode, we take a closer look at how Xylazine, a drug initially intended for veterinary use, is making its way into recreational drugs across America and Canada. We also discuss the recent FDA approval of Narcan for over-the-counter use, a $462 million dollar 'vape usage crisis' lawsuit, and how Ghana became the first country in the world to approve a new Malaria vaccine, the R21 Matrix-M vaccine.
(04:04) Xylazine
(06:11) FDA approval of Narcan for over-the-counter use
(08:20) Vape usage crisis
(10:42) New Malaria vaccine
Please head to our website at 2minutemedicine.com to learn more and to access all of our content including medical study summaries, visual abstracts, excerpts from our Classics book series which is available on Amazon, and The Scan, which is our medical newsletter. To make sure that you don’t miss any of our content please subscribe and follow us on Twitter or Instagram @2minmed!
